Eyegate Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Eyegate Pharmaceuticals Inc
CIK #0001372514
EDGAR Form CIK 2011 - 2026
10-K [0001372514]
10-Q [0001372514]
3 [0001372514]
4 [0001372514]
8-K [0001372514]
D [0001372514]
SC 13D [0001372514]
SC 13G [0001372514]
Form 13D/13G Filer Form 13D/13G Subject Filed
Alyeska Investment Group LP Kiora Pharmaceuticals Inc [2026-05-15]
Nantahala Capital Partners Limited Partnership Kiora Pharmaceuticals Inc [2025-08-14]
Nantahala Capital Management LLC Kiora Pharmaceuticals Inc [2024-11-14]
ADAR1 Capital Management LLC Kiora Pharmaceuticals Inc [2024-11-14]
Alyeska Investment Group LP Kiora Pharmaceuticals Inc [2024-11-14]
Goldman Sachs Group Inc Kiora Pharmaceuticals Inc [2024-11-12]
Rosalind Advisors Inc Kiora Pharmaceuticals Inc [2024-05-29]
Rosalind Advisors Inc Kiora Pharmaceuticals Inc [2024-05-29]
Stonepine Capital Management LLC Kiora Pharmaceuticals Inc [2024-02-09]
Hirschman Orin Kiora Pharmaceuticals Inc [2024-02-07]
View All
Form 3/4/5 Subject 2011 - 2026
Strem Brian M
Kiora Pharmaceuticals Inc
Tosca Melissa
Stengone Carmine N
Parsons Erin
Hollander David
Walters-Hoffert Lisa
Shapiro Aron
Tyle Praveen
Daniels Eric Joseph
Gayron Kenneth L
Chaney Paul G
Drexler Susan L
Romano Sarah
From Stephen
Mann Brenda
Manzo Michael P
Armistice Capital Master Fund Ltd
Boyd Steven
Armistice Capital LLC
Hancock Thomas
Malfroy-Camine Bernard
Goldberg Morton
Obermayr Franz
Maher Illya Keith
Wirostko Barbara
Greenleaf Peter
Garanzini Michael
Balland Thomas
Ventech Capital II
Brenneman Ryan Randall
Chaoui Mounia
FCPR Ventech B
Natixis Private Equity
IPSA Innoven Partenaires Sa
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kiora Pharmaceuticals Inc KPRX
Common Stock
2026-03-06 Grant 6,533 $0.00
Kiora Pharmaceuticals Inc KPRX
Common Stock
2026-03-06 Grant 6,533 $0.00
Kiora Pharmaceuticals Inc KPRX
Common Stock
2026-03-06 Grant 16,733 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2026-03-06 Grant 33,467 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2026-03-06 Grant 13,067 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2026-03-06 Grant 13,067 $0.00
Kiora Pharmaceuticals Inc KPRX
Common Stock
2026-03-03 Tax withheld 238 $2.02 481
Kiora Pharmaceuticals Inc KPRX
Common Stock
2026-03-03 Tax withheld 238 $2.02 481
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 20,000 $0.00
Kiora Pharmaceuticals Inc KPRX
Common Stock
2025-04-01 Grant 15,941 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 20,000 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 20,000 $0.00
Kiora Pharmaceuticals Inc KPRX
Common Stock
2025-04-01 Grant 7,772 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 31,883 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 30,000 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 15,543 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 20,000 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 20,000 $0.00
Kiora Pharmaceuticals Inc KPRX
Common Stock
2025-04-01 Grant 7,772 $0.00
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
2025-04-01 Grant 15,543 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com